Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals (NASDAQCM:ORMP) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an orally ingestible insulin capsule currently in Phase 2 trials under the USFDA, the Company is seeking to revolutionize the treatment of diabetes.